Back to search

University of British Columbia

Metalloproteinase cleavage of versican at the fibroblast cell surface

Abstract

dc:description

Versican is a large aggregating proteoglycan expressed in the pericellular matrix of fibroblast cells. It is highly expressed during development and remodeling. The regulated synthesis and degradation of versican are associated with physiological remodeling. Versican is expressed in fibroproliferative lesions of human pulmonary fibrosis and atherosclerosis. Stromal expression of versican is associated with many forms of cancer and may be predictive of poor prognosis. Abnormal persistence of the versican-rich matrix may contribute to fibroproliferative and oncogenic processes. The process of versican degradation is not understood, but as versican is a pericellular molecule, physiological degradation likely involves cell surface-associated proteolysis. As such, the overarching hypothesis for this work is that regulated versican turnover involves the cell surface-associated metalloproteinases ADAMTS-2, MMP-2 and MT1-MMP, that are expressed in versican-rich remodeling lesions. ADAMTS-2 is a procollagen N-propeptidase involved in collagen fibrillogenesis. As procollagen is synthesized in a versican-rich matrix, it was hypothesized that ADAMTS- 2 might bind and process versican. MMP-2 and MT1-MMP in complex with TIMP-2, are activated at the cell surface during wound healing, pulmonary fibrosis and cancer. Versican was purified from human fetal lung fibroblast cultures for in vitro proteolysis experiments. The purified versican preparation was characterized by electrophoresis, chromatography, spectrophotometry and mass spectrometry. ADAMTS-2 and versican localization in normal and fibrotic human lungs were investigated. ADAMTS-2 was shown to co-purify with versican from human fetal lung fibroblasts. Bovine ADAMTS-2 was purified from fetal calf skin and shown to cleave purified human versican. The plant lectin concanavalin-A (ConA) induces a matrix degradative phenotype and is used here to investigate the process of versican degradation relative to apoptotic iii events in human fetal lung fibroblast cultures. Con-A induced increased expression of MMP-2 and MT1-MMP in human fetal lung fibroblasts and a concomitant loss of versican from the matrix. Microarray analysis was used to investigate expression of possible versican-degrading enzymes and their inhibitors, expressed in response to ConA. Recombinant MMP-2 and MT1-MMP were shown to process purified versican in vitro. This work expands upon the body of knowledge of versican turnover and should help in the search for therapeutic avenues to treat fibroproliferative and oncogenic processes.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Dental Science
Grantor dc:publisher
University of British Columbia
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Maurice, Sean Bertram

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/14410

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Maurice, Sean Bertram. Metalloproteinase cleavage of versican at the fibroblast cell surface. doctoral thesis, University of British Columbia, 2009. http://hdl.handle.net/2429/14410